ABBOTT LABORATORIES — Director's Dealing 2017

Jan 25, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-01-16

Reporting Person: MANNING JOSEPH J (Senior Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	20492	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$25.2461	2017-02-15	Common shares (100)		Direct
Option (right to buy)	$25.2461	2017-02-15	Common shares (100)		Direct
Option (right to buy)	$25.2461	2017-02-15	Common shares (100)		Direct
Option (right to buy)	$26.6973	2018-02-14	Common shares (1067)		Direct
Option (right to buy)	$26.6973	2018-02-14	Common shares (1067)		Direct
Option (right to buy)	$26.6973	2018-02-14	Common shares (1066)		Direct
Option (right to buy)	$47	2025-02-19	Common shares (15742)		Direct
Option (right to buy)	$47	2025-02-19	Common shares (15742)		Direct
Option (right to buy)	$47	2025-02-19	Common shares (15742)		Direct
Option (right to buy)	$38.40	2026-02-18	Common shares (25000)		Direct
Option (right to buy)	$38.40	2026-02-18	Common shares (25000)		Direct
Option (right to buy)	$38.40	2026-02-18	Common shares (25000)		Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.